News & Updates
Filter by Specialty:
On-body injector on par with traditional injection in preventing severe neutropaenia
Pegfilgrastim on-body injectors (OBI) are as effective as traditional injection for the prevention of severe neutropaenia (SN), neutropaenic fever, and neutropaenia in breast cancer patients, reveals a study.
On-body injector on par with traditional injection in preventing severe neutropaenia
05 Feb 2022
Obese breast cancer patients on T-DM1 prone to more treatment adjustments
More treatment modifications secondary to adverse events appear necessary among obese patients receiving ado-trastuzumab emtansine (T-DM1), an antibody-drug conjugate indicated for the treatment of HER2-positive breast cancer, relative to nonobese counterparts, reports a study.
Obese breast cancer patients on T-DM1 prone to more treatment adjustments
04 Feb 2022
Risk of colorectal cancer mortality after adenoma removal differs by sex
Women appear to be at higher risk of colorectal cancer death following adenoma removal, whereas men are at lower risk, as reported in a recent study.
Risk of colorectal cancer mortality after adenoma removal differs by sex
02 Feb 2022
Lifestyle interventions ward off mobility disability in prostate cancer patients on ADT
An exercise and dietary lifestyle intervention regimen leads to better mobility outcomes among prostate cancer patients undergoing androgen deprivation therapy (ADT) as compared with standard-of-care management, a recent study has found. Moreover, social cognitive outcome measures seem to be predictive of such mobility outcomes.